Day One Biopharmaceutical... (DAWN)
11.60
0.44 (3.94%)
At close: Jan 15, 2025, 12:49 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -188.92M | -142.18M | -72.75M | -43.84M | -16.98M |
| Depreciation & Amortization | 383.00K | 531.00K | 199.00K | 155.00K | n/a |
| Stock-Based Compensation | 39.34M | 27.24M | 13.32M | 526.00K | 111.00K |
| Other Working Capital | 7.10M | 8.05M | 1.15M | -489.00K | 430.00K |
| Other Non-Cash Items | -7.08M | -2.03M | 8.00M | 30.03M | 11.91M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 9.42M | 6.56M | 2.69M | -357.00K | 444.00K |
| Operating Cash Flow | -146.85M | -109.87M | -48.54M | -13.49M | -4.51M |
| Capital Expenditures | -3.22M | -26.00K | -8.00M | -92.00K | n/a |
| Acquisitions | n/a | 255.05K | n/a | n/a | n/a |
| Purchase of Investments | -443.84M | -394.21M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 575.44M | 139.16M | n/a | n/a | n/a |
| Other Investing Acitivies | -3.00M | -255.05K | -8.00M | n/a | n/a |
| Investing Cash Flow | 128.38M | -255.07M | -8.00M | -92.00K | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | 1.00M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 5.18M | 4.29M | 130.07M | 29.98M | 29.91M |
| Financial Cash Flow | 164.00M | 165.90M | 297.12M | 29.98M | 30.91M |
| Net Cash Flow | 145.52M | -199.05M | 240.58M | 16.40M | 26.39M |
| Free Cash Flow | -150.08M | -109.90M | -56.54M | -13.58M | -4.51M |